SIMCERE PHARMA (02096) spent 10.1667 million Hong Kong dollars to repurchase 1.49 million shares on November 18th.
Sinopharm (02096) announced that on November 18, 2024, the company invested 1016.67 million...
SIMCERE PHARMA (02096) announced that on November 18, 2024, the company repurchased 1.49 million shares at a cost of 10.167 million Hong Kong dollars. The repurchase price was between 6.71 and 6.98 Hong Kong dollars per share.
Related Articles
CMB International claimed that AI PCs will become the mainstream model by 2026. Lenovo (00992) is relying on its memory strategy to stockpile and defend against the competition.
Bitcoin "hoarding whales" strategy (MSTR.US) secures a spot on the Nasdaq 100 MSCI Index still warns of potential removal in January.
Intel Corporation (INTC.US) is close to acquiring the AI chip startup company SambaNova for nearly $1.6 billion.
CMB International claimed that AI PCs will become the mainstream model by 2026. Lenovo (00992) is relying on its memory strategy to stockpile and defend against the competition.
Bitcoin "hoarding whales" strategy (MSTR.US) secures a spot on the Nasdaq 100 MSCI Index still warns of potential removal in January.
Intel Corporation (INTC.US) is close to acquiring the AI chip startup company SambaNova for nearly $1.6 billion.
RECOMMEND
Valued At $10 Trillion, The Largest IPO In History Is Coming As SpaceX Announces Listing Plan
12/12/2025
Five Imperatives And Eight Tasks: Central Meeting Specifies Next Year’s Economic Work, Highlights Identified
12/12/2025
Over 100 New Listings In Hong Kong This Year As Total Fundraising Tops HKD 270 Billion, Eighteen “A+H” Dual Listings
12/12/2025
